导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.95% | 448/1050 |
| 近一周 | -2.01% | 407/1104 |
| 近一月 | -1.87% | 207/1102 |
| 近一季 | -5.94% | 464/1092 |
| 近半年 | -3.10% | 527/1070 |
| 近一年 | 8.12% | 385/1018 |
| 近两年 | 84.80% | 254/926 |
| 近三年 | 46.46% | 277/834 |
| 成立以来 | 129.15% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.80% 546/1070 |
12.19% 518/1101 |
- - |
- - |
| 2025 | 39.63% 332/1065 |
5.70% 360/1014 |
7.50% 181/1038 |
18.43% 651/1050 |
3.76% 205/1065 |
| 2024 | 3.76% 470/1011 |
-5.31% 581/960 |
-4.57% 611/983 |
12.26% 439/991 |
2.28% 227/1011 |
| 2023 | 6.16% 39/952 |
10.87% 96/880 |
0.07% 187/895 |
-2.60% 188/915 |
-1.76% 211/952 |
| 2022 | -4.64% 37/867 |
-8.94% 86/773 |
7.09% 398/806 |
-6.46% 96/845 |
4.54% 230/867 |
| 2021 | 28.12% 84/740 |
6.74% 34/580 |
16.23% 219/659 |
0.11% 214/704 |
3.16% 299/740 |
| 2020 | 24.05% 372/554 |
-3.47% 245/419 |
17.35% 325/466 |
8.43% 292/517 |
0.99% 482/554 |
| 2019 | 27.12% 304/410 |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏智胜价值成长C VS. 东吴新产业精选股票A(580008) |